Lewis, Annabelle <br/><br/>
A polymorphic enhancer near GREM1 influences bowel cancer risk through differential CDX2 and TCF7L2 binding.  [electronic resource] 

 -  Cell reports  Aug 2014 
 - 983-90 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2211-1247 
<br/><br/><label>Standard No.: </label>10.1016/j.celrep.2014.07.020  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Base Sequence<br/>CDX2 Transcription Factor<br/>Cell Line, Tumor<br/>Colonic Neoplasms--genetics<br/>Enhancer Elements, Genetic<br/>Gene Expression Regulation, Neoplastic<br/>Genetic Association Studies<br/>Genetic Predisposition to Disease<br/>Homeodomain Proteins--metabolism<br/>Humans<br/>Intercellular Signaling Peptides and Proteins--genetics<br/>Mice, Transgenic<br/>Organ Specificity<br/>Polymorphism, Single Nucleotide<br/>Risk<br/>Transcription Factor 7-Like 2 Protein--metabolism